GlassScriptPhysician profile
Timothy Frazier
NPI 1124259296
$12,889.91
in general payments reported to CMS, 2019-2025
13 companies · $1,798 in 2025
The $1,798 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,750 · 2020: $665 · 2021: $1,765 · 2022: $3,525 · 2023: $1,509 · 2024: $878 · 2025: $1,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,207 · Food and Beverage: $978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,207.39 |
| Food and Beverage | $977.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,082.43 | 2021-2025 | |
| Supreme Orthopedic Systems, LLC | $4,716.51 | 2020-2025 | |
| Stryker Corporation | $1,966.86 | 2019-2021 | |
| Linvatec Corporation | $565.67 | 2019-2021 | |
| Horizon Therapeutics Plc | $148.50 | 2019 | |
| Native Surgical, LLC | $148.42 | 2025 | |
| Smith+Nephew, INC. | $146.00 | 2019 | |
| Bioventus LLC | $24.64 | 2019 | |
| Electronic Waveform Lab, INC. | $21.84 | 2025 | |
| Nevro Corp. | $19.28 | 2023 | Senza |
| Curonix LLC | $17.49 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Acelrx Pharmaceuticals, INC. | $17.45 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $14.82 | 2024 | Lockado |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Frazier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.